Opioids
More on Opioids
Washington, D.C. (Mar. 6, 2019)—On Thursday, March 7, 2019, the Committee on Oversight and Reform will hold a hearing on "The Trump Administration's Response to the Drug Crisis."
WHERE: 2154 Rayburn House Office Building
WHEN: Thursday, March 7, 2019
TIME: 10:00 a.m.
PURPOSE
| Washington, D.C. (Feb. 1, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 12, 2019. The hearing will cover President Trump's first-ever National Drug Control Strategy, which the White House released yesterday. |
Washington, D.C. (Sept. 28, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, delivered a floor statement applauding passage of the Substance Abuse Prevention Act, which reauthorizes and reforms the Office of National Drug Control Policy (ONDCP). This legislation was based on H.R. 5925, the Coordinated Response through Interagency Strategy and Information Sharing (CRISIS) Act, bipartisan legislation that passed the House on June 20, 2018.
Washington, D.C. (July 27, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, and Senator Elizabeth Warren held a roundtable with Maryland Senator Ben Cardin and Congressman John Sarbanes, Baltimore officials, health professionals, and community representatives to discuss the challenges they face in combating the opioid epidemic and the urgent need for new resources to expand treatment.
Washington, D.C. (July 23, 2018)—On Friday, July 27, 2018, at 10 am, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, and Senator Elizabeth Warren will hold a roundtable with Members of Congress, Baltimore officials, and community representatives to discuss the challenges they face in combating the opioid epidemic and the urgent need for new resources to expand treatment.
Washington, DC – Today, Congressman Mark DeSaulnier and Ranking Member of the Oversight and Government Reform Committee Elijah E. Cummings sent a letter requesting that Chairman Trey Gowdy issue a subpoena to compel the Department of Justice (DOJ) to produce documents it is withholding related to an internal 2006 report that Purdue Pharma knew of significant abuses of its drug OxyContin shortly after it was brought to market in 1996.
Washington, D.C. (June 28, 2018)—Today, Rep. Elijah E. Cummings, the Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement at the conclusion of House Republicans' so-called "Opioid Week," which actually extended over parts of the past two weeks:
TOP HOUSE DEMOCRATS DEMAND
ANSWERS & DOCUMENTS FROM
DOJ FOLLOWING REFUSAL TO DEFEND ACA
DeSaulnier and Cummings Call on AG Sessions to Produce DOJ Report Showing Purdue Pharma Concealed Knowledge of OxyContin Abuses